Barbara E K Klein1, Michael D Knudtson, Michael Y Tsai, Ronald Klein. 1. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Wisconsin Alumni Research Foundation, Madison, WI 53726, USA. kleinb@epi.ophth.wisc.edu
Abstract
OBJECTIVE: To determine the relation of glycemia, blood pressure, and serum total cholesterol level as systemic markers of inflammation and endothelial dysfunction to the prevalence and incidence of diabetic retinal outcomes in persons with long-duration type 1 diabetes mellitus. METHODS: Longitudinal population-based study of persons with type 1 diabetes mellitus who received care for their diabetes in south central Wisconsin from July 1, 1979, to June 30, 1980. Data for this investigation were obtained from the 1990-1992 through the 2005-2007 follow-up examinations. Main outcome measures included the severity of diabetic retinopathy (DR) and macular edema (ME). RESULTS: In the 1990-1992 prevalence data, soluble vascular cell adhesion molecule, tumor necrosis factor, and homocysteine levels were associated with increased odds of more severe DR (odds ratios [highest vs lowest quartile], 3.95 [95% confidence interval, 1.66-9.39], 5.46 [2.38-12.52], and 7.46 [2.91-19.16], respectively) in those with kidney disease while controlling for relevant confounders. Similar odds were found for proliferative DR. Only total homocysteine level was associated with increased odds of ME (3.80 [95% confidence interval, 1.91-7.54]), irrespective of kidney disease. None of the markers were associated with incidence of proliferative DR, ME, or progression of DR 15 years later. CONCLUSIONS: A limited number of markers are associated with increased odds of prevalent retinal outcomes in persons with type 1 diabetes mellitus and kidney disease. Only homocysteine level is associated with ME in those with and without kidney disease. In the absence of kidney disease, the markers do not add to the more conventional descriptors and predictors of DR in persons with type 1 diabetes mellitus. This may reflect the close association of DR and kidney disease in diabetic persons.
OBJECTIVE: To determine the relation of glycemia, blood pressure, and serum total cholesterol level as systemic markers of inflammation and endothelial dysfunction to the prevalence and incidence of diabetic retinal outcomes in persons with long-duration type 1 diabetes mellitus. METHODS: Longitudinal population-based study of persons with type 1 diabetes mellitus who received care for their diabetes in south central Wisconsin from July 1, 1979, to June 30, 1980. Data for this investigation were obtained from the 1990-1992 through the 2005-2007 follow-up examinations. Main outcome measures included the severity of diabetic retinopathy (DR) and macular edema (ME). RESULTS: In the 1990-1992 prevalence data, soluble vascular cell adhesion molecule, tumornecrosis factor, and homocysteine levels were associated with increased odds of more severe DR (odds ratios [highest vs lowest quartile], 3.95 [95% confidence interval, 1.66-9.39], 5.46 [2.38-12.52], and 7.46 [2.91-19.16], respectively) in those with kidney disease while controlling for relevant confounders. Similar odds were found for proliferative DR. Only total homocysteine level was associated with increased odds of ME (3.80 [95% confidence interval, 1.91-7.54]), irrespective of kidney disease. None of the markers were associated with incidence of proliferative DR, ME, or progression of DR 15 years later. CONCLUSIONS: A limited number of markers are associated with increased odds of prevalent retinal outcomes in persons with type 1 diabetes mellitus and kidney disease. Only homocysteine level is associated with ME in those with and without kidney disease. In the absence of kidney disease, the markers do not add to the more conventional descriptors and predictors of DR in persons with type 1 diabetes mellitus. This may reflect the close association of DR and kidney disease in diabeticpersons.
Authors: O Vaccaro; A F Perna; F P Mancini; C Iovine; V Cuomo; M Sacco; A Tufano; A A Rivellese; D Ingrosso; G Riccardi Journal: Nutr Metab Cardiovasc Dis Date: 2000-12 Impact factor: 4.222
Authors: M I Cybulsky; K Iiyama; H Li; S Zhu; M Chen; M Iiyama; V Davis; J C Gutierrez-Ramos; P W Connelly; D S Milstone Journal: J Clin Invest Date: 2001-05 Impact factor: 14.808
Authors: D Fukumura; T Gohongi; A Kadambi; Y Izumi; J Ang; C O Yun; D G Buerk; P L Huang; R K Jain Journal: Proc Natl Acad Sci U S A Date: 2001-02-27 Impact factor: 11.205
Authors: T Yuuki; T Kanda; Y Kimura; N Kotajima; J Tamura; I Kobayashi; S Kishi Journal: J Diabetes Complications Date: 2001 Sep-Oct Impact factor: 2.852
Authors: E K Hoogeveen; P J Kostense; P E Eysink; B C Polak; P J Beks; C Jakobs; J M Dekker; G Nijpels; R J Heine; L M Bouter; C D Stehouwer Journal: Arch Intern Med Date: 2000-10-23
Authors: Hussein A Rajab; Nathaniel L Baker; Kelly J Hunt; Richard Klein; Patricia A Cleary; John Lachin; Gabriel Virella; Maria F Lopes-Virella Journal: J Diabetes Complications Date: 2014-08-20 Impact factor: 2.852
Authors: Jane Z Kuo; Xiuqing Guo; Ronald Klein; Barbara E Klein; Jinrui Cui; Jerome I Rotter; Eli Ipp; Yii-Der Ida Chen Journal: Ophthalmology Date: 2012-02-11 Impact factor: 12.079
Authors: Juan E Grunwald; Judith Alexander; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker; Kathleen McWilliams; Joan C Lo; Alan Go; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie; Bernard G Jaar Journal: Arch Ophthalmol Date: 2012-09
Authors: Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker-Ostroff; Emile Mohler; Joan C Lo; Raymond R Townsend; Crystal Ann Gadegbeku; James Phillip Lash; Jeffrey Craig Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie Journal: Am J Cardiol Date: 2015-08-31 Impact factor: 2.778